Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated drug candidates. Its stereochemistry and fluorine substitution pattern make it valuable for optimizing metabolic stability and binding affinity in active compounds. Commonly employed in asymmetric synthesis routes where the hydroxyl group can be further functionalized, such as in esterification or ether formation, to build more complex bioactive molecules. Also utilized in the preparation of receptor agonists or enzyme inhibitors where fluorinated aromatic moieties enhance pharmacokinetic properties.